Fresenius Medical Care North America Appoints Angela McClure to Chief Experience Officer
New role focuses on enterprise-wide experience strategy reaching all audiences WALTHAM, Mass., March 20, 2018 -- (Healthcare Sales & Marketing Network) -- Fresenius Medical Care North America (FMCNA), the country's leading provider of kidney care produ... Devices, Personnel Fresenius, dialysis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 20, 2018 Category: Pharmaceuticals Source Type: news

Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain
TEL AVIV, Israel, March 20, 2018 -- (Healthcare Sales & Marketing Network) -- Therapix Biosciences Ltd. (NASDAQ: TRPX) ("Therapix" or the "Company"), a biopharmaceutical company focused on discovering, developing, and commercializing n... Biopharmaceuticals, FDA Therapix Biosciences, cannabinoid, THX-110, Low Back Pain (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 20, 2018 Category: Pharmaceuticals Source Type: news

Mylan Adds to Growing Oncology Portfolio with Launch of Generic Mutamycin(R) Injection
Mitomycin for Injection is available to Mylan's hospital and other institutional customers HERTFORDSHIRE, England and PITTSBURGH, March 20, 2018 -- (Healthcare Sales & Marketing Network) -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today a... Biopharmaceuticals, Generics, Oncology, Product Launch Mylan, Bristol Myers Squibb, Mitomycin, Mutamycin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 20, 2018 Category: Pharmaceuticals Source Type: news

Bionik Laboratories Appoints Peter Gerald Malone and Joseph Martin to its Board of Directors
Gains substantial strategic and operational experience within the equity capital markets and the healthcare industry TORONTO and BOSTON, March 20, 2018 -- (Healthcare Sales & Marketing Network) -- Bionik Laboratories Corp. (OTCQB: BNKL) ("Bionik&q... Devices, Neurology, Personnel Bionik Laboratories, lower extremity rehabilitation, stroke (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 20, 2018 Category: Pharmaceuticals Source Type: news

Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease
MALVERN, Pa., March 20, 2018 -- (Healthcare Sales & Marketing Network) -- Ocugen, Inc., a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved ocular diseases, today announced ... Biopharmaceuticals, Ophthalmology Ocugen , OCU310, dry eye disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 20, 2018 Category: Pharmaceuticals Source Type: news

Mark Stenhouse to join Exact Sciences as President, Cologuard
After leading HUMIRA sales and marketing to create a blockbuster drug, Abbott Laboratories/AbbVie executive to join Cologuard team MADISON, Wis., March 20, 2018 -- (Healthcare Sales & Marketing Network) -- Exact Sciences Corp. (Nasdaq: EXAS), the compa... Diagnostics, Oncology, Personnel Exact Sciences, Cologuard, colorectal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 20, 2018 Category: Pharmaceuticals Source Type: news

Abbott's MitraClip Therapy Receives National Reimbursement in Japan to Treat Patients with Mitral Regurgitation
National reimbursement adds the device into Japan's health insurance system, which enables greater access for patients MitraClip is a first-of-its-kind transcatheter mitral valve repair device that provides physicians with a minimally invasive way to re... Devices, Cardiology, Reimbursement Abbott, MitraClip, mitral regurgitation, mitral valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

LifeNet Health launches unique, life-saving vascular allograft
AngioGraft® Aortoiliac Artery, the first to offer pressurized sizing, offers unparalleled efficiency and precision in aortic reconstruction VIRGINIA BEACH, Va., March 19, 2018 -- (Healthcare Sales & Marketing Network) -- LifeNet Health today announc... Devices, Cardiology, Surgery, Product Launch LifeNet Health, AngioGraft, Aortoiliac Artery, vascular allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

Amplyx Pharmaceuticals Receives Fourth "Qualified Infectious Disease Product" (QIDP) Designation from the FDA for APX001
QIDP Designation Granted for Treatment of Cryptococcosis Provides Priority Review, Fast-Track Status and Five Additional Years of Market Exclusivity SAN DIEGO, March 19, 2018 -- (Healthcare Sales & Marketing Network) -- Amplyx Pharmaceuticals, a compan... Biopharmaceuticals, FDA Amplyx Pharmaceuticals, Candida, Aspergillus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

Edwards' Acumen Hypotension Prediction Index Launches In The U.S.
IRVINE, Calif., March 19, 2018 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the U... Devices, Monitoring, FDA, Product Launch Edwards Lifesciences, Acumen, Hypotension Prediction Index (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

PMV Pharma Appoints Salim Yazji, M.D. as Chief Medical Officer
CRANBURY, N.J., March 19, 2018 -- (Healthcare Sales & Marketing Network) -- PMV Pharmaceuticals, Inc., a leader in the discovery and development of p53-targeted small molecule drugs for the treatment of cancer, today announced the appointment of Dr. Salim... Biopharmaceuticals, Oncology, Personnel PMV Pharma, p53 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

UNITY Biotechnology, Inc. Completes $55 Million Series C Financing
Proceeds to Support Advancement of Pipeline into Clinical Studies SAN FRANCISCO, March 19, 2018 -- (Healthcare Sales & Marketing Network) -- UNITY Biotechnology, Inc. ("UNITY"), a privately held biotechnology company developing therapeutics t... Biopharmaceuticals, Venture Capital UNITY Biotechnology, senolytic medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

Mallinckrodt Completes Sale Of RECOTHROM(R) And PREVELEAK(R) To Baxter
Transaction supports Mallinckrodt's transformation to an innovation-driven specialty pharmaceutical growth company focused on improving outcomes for patients with severe and critical conditions STAINES-UPON-THAMES, United Kingdom, March 19, 2018 -- (Hea... Biopharmaceuticals, Acquisitions Mallinckrodt, Baxter International, RECOTHROM, PREVELEAK (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

EYLEA(R) (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial
Expect U.S. regulatory submission for diabetic retinopathy later this year TARRYTOWN, N.Y., March 19, 2018 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Phase 3 PANORAMA trial evalu... Biopharmaceuticals, Ophthalmology Regeneron Pharmaceuticals, EYLEA, aflibercept, macular degeneration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada
License Agreement Advances First-in-Class Tenapanor for IBS-C and Hyperphosphatemia in Canada Ardelyx to Receive Up to CAD 25 Million in Upfront Payment and Subsequent Milestones FREMONT, Calif., March 19, 2018 -- (Healthcare Sales & Marketing Networ... Biopharmaceuticals, Gastroenterology, Licensing Ardelyx, Knight Therapeutics, tenapanor, inflammatory bowel (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 19, 2018 Category: Pharmaceuticals Source Type: news

Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain
NEW YORK, March 16, 2018 -- (Healthcare Sales & Marketing Network) -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, and Bio-Nucleonics, licensor of Strontium 89 Chloride, announce submission of a regulator... Biopharmaceuticals, Oncology, FDA Q Biomed, Strontium 89 Chloride, Bone Pain (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 16, 2018 Category: Pharmaceuticals Source Type: news

Vascular Insights(R) Announces A New Lead To The Global Commercial Team
Chip Draper to serve as Senior Vice President of Worldwide Sales & Marketing leading global commercial initiatives QUINCY, Mass., March 16, 2018 -- (Healthcare Sales & Marketing Network) -- Vascular Insights® announced that Chip Draper has been app... Devices, Interventional, Personnel Vascular Insights, ClariVein (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 16, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
First and only subcutaneous immunoglobulin (SCIg) approved for the treatment of CIDP based on the largest controlled clinical study in CIDP KING OF PRUSSIA, Pa., March 16, 2018 -- (Healthcare Sales & Marketing Network) -- Global biotherapeutics leader ... Biopharmaceuticals, FDA CSL Behring, Hizentra, Immune Globulin, CIDP (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 16, 2018 Category: Pharmaceuticals Source Type: news

Johnson and Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
NEW BRUNSWICK, N.J., March 16, 2018 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business f... Devices, Monitoring, Endocrinology, Acquisitions Johnson & Johnson, LifeScan, OneTouch, blood glucose monitor, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 16, 2018 Category: Pharmaceuticals Source Type: news

Organogenesis Announces New PuraPly(R) Antimicrobial Small Size
CANTON, Mass., March 15, 2018 -- (Healthcare Sales & Marketing Network) -- Organogenesis Inc., a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical... Devices, Surgery, Wound Care, Product Launch Organogenesis, PuraPly Antimicrobial (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 15, 2018 Category: Pharmaceuticals Source Type: news

Esaote Launches MyLab(TM) 9 eXP Ultrasound System at the AIUM 2018
New High-End Shared Service Ultrasound System at an Ultra-Value FISHERS, Ind., March 15, 2018 -- (Healthcare Sales & Marketing Network) -- Responding to the market need for a true shared service system, with advanced applications, easy workflow, indust... Devices, Product Launch Esaote, MyLab 9 eXP, Ultrasound (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 15, 2018 Category: Pharmaceuticals Source Type: news

Intezyne Taps Veteran Banker E. Russell McAllister as President and CEO
TAMPA, Fla., March 15, 2018 -- (Healthcare Sales & Marketing Network) -- Intezyne, a clinical-stage biopharmaceutical company headquartered at the USF Tampa Bay Technology Incubator, announced that the company's Chief Financial Officer, E. Russell McAllis... Biopharmaceuticals, Oncology, Personnel Intezyne Technologies, Cancer Resistance Pathway (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 15, 2018 Category: Pharmaceuticals Source Type: news

Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer
Erdafitinib, an oral pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, shows promise as the first targeted agent for patients with metastatic urothelial cancer, one of the most common cancers RARITAN, N.J., March 15, 2018 -- (Healt... Biopharmaceuticals, Oncology, Urology, FDA Janssen Pharmaceutical, erdafitinib, Urothelial Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 15, 2018 Category: Pharmaceuticals Source Type: news

DxNow, Inc. Receives FDA 510(k) Clearance for ZyMand#333;t(TM) ICSI and ZyMand#333;t(TM) Multi Sperm Separation Devices
Novel Devices Advance Fertility Treatment for Millions of Couples Striving to Conceive GAITHERSBURG, Md., March 15, 2018 -- (Healthcare Sales & Marketing Network) -- DxNow, Inc., a privately held medical device company, announces receipt of FDA 510(k) ... Devices, FDA DxNow, ZyMōt, assisted reproductive technology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 15, 2018 Category: Pharmaceuticals Source Type: news

Ionis and Akcea Partner to Commercialize Inotersen for hATTR
Ionis licenses to Akcea worldwide rights to inotersen and IONIS-TTR-L Rx Collaboration advances commercial readiness for planned mid-2018 inotersen launch, positioning Akcea to successfully launch two drugs for significant rare diseases this year Ion... Biopharmaceuticals, Licensing Ionis Pharmaceuticals, Akcea Therapeutics, inotersen, AKCEA-TTR-LRx (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 15, 2018 Category: Pharmaceuticals Source Type: news

Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing
Former Amgen executive will oversee company’s pharmaceutical manufacturing operations LOS ANGELES, March 14, 2018 -- (Healthcare Sales & Marketing Network) -- CURE Pharmaceutical, (OTC:CURR), an innovative drug delivery and development company, today na... Biopharmaceuticals, Drug Delivery, Personnel CURE Pharmaceutical, CUREfilm (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2018 Category: Pharmaceuticals Source Type: news

Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery
Pivotal study to evaluate next-generation synthetic small peptide technology (P-15) compared to autograft in most common spine procedure WESTMINSTER, Colo., March 14, 2018 -- (Healthcare Sales & Marketing Network) -- Cerapedics, a privately-held orthob... Devices, Orthopaedic, FDA Cerapedics, orthobiologic, i-FACTOR, Peptide Enhanced Bone Graft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2018 Category: Pharmaceuticals Source Type: news

Sight Sciences Names Jesse Selnick Chief Financial Officer
Accomplished Executive to Help Lead the Company's Expansion and Strategic Growth MENLO PARK, Calif., March 14, 2018 -- (Healthcare Sales & Marketing Network) -- Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest gr... Devices, Ophthalmology, Personnel Sight Sciences, VISCO360, TRAB360 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2018 Category: Pharmaceuticals Source Type: news

Torque Appoints John Hohneker, MD, to Board of Directors and Marcela Maus, MD, PhD, to Scientific Advisory Board
CAMBRIDGE, Mass., March 14, 2018 -- (Healthcare Sales & Marketing Network) -- Torque, an immuno-oncology company developing Deep Primed™ cell therapeutics with pharmacologic control to drive a full immune response within the tumor microenvironment, announ... Biopharmaceuticals, Oncology, Personnel Torque, Deep Primed, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2018 Category: Pharmaceuticals Source Type: news

Pharmaceutical Startup, Bridge Therapeutics, Announces Tim Peara Will Be Joining the Company as the Director of Finance
BIRMINGHAM, Ala., March 14, 2018 -- (Healthcare Sales & Marketing Network) -- The innovative late development-stage pharmaceutical startup, Bridge Therapeutics® has announced Tim Peara will be joining its management team as the new Director of Finance... Biopharmaceuticals, Drug Delivery, Personnel Bridge Therapeutics, buprenorphine, meloxicam, sublingual (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 14, 2018 Category: Pharmaceuticals Source Type: news

Exalenz Bioscience’s BreathID(R) Hp and BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients
Important new testing option for an infection that impacts nearly 20 million U.S. children and may have significant negative impacts on long-term health MODI'IN, Israel and MANASQUAN, N.J., March 13, 2018 -- (Healthcare Sales & Marketing Network) -- Exa... Diagnostics, FDA Exalenz Bioscience, BreathID, Helicobacter pylori, H. pylori (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 13, 2018 Category: Pharmaceuticals Source Type: news

Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
MINNEAPOLIS, March 13, 2018 -- (Healthcare Sales & Marketing Network) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., has secured a ... Biopharmaceuticals, Personalized Medicine, Licensing Precision Therapeutics, TumorGenesis, SyntArray, STREAMWAY (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 13, 2018 Category: Pharmaceuticals Source Type: news

Cogmedix Welcomes David Fraser as New Senior Vice President of Operations
WORCESTER, Mass., March 13, 2018 -- (Healthcare Sales & Marketing Network) -- Worcester medical device manufacturer, Cogmedix, welcomes David Fraser as its new Senior Vice President of Operations. The addition is part of a continued effort to broaden and ... Devices, Personnel Cogmedix (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 13, 2018 Category: Pharmaceuticals Source Type: news

Astellas Announces Key Leadership Changes in Legal, Human Resources
NORTHBROOK, Ill., March 13, 2018 -- (Healthcare Sales & Marketing Network) -- Astellas today announced three senior-level changes in its global Legal and Human Resources organizations. Roderick (Rod) Christmon is promoted to executive director, Medical... Biopharmaceuticals, Personnel Astellas (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 13, 2018 Category: Pharmaceuticals Source Type: news

Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes
'Smart' CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management DUBLIN - March 12, 2018 - Medtronic plc (NYSE:MDT), the global leader in med... Devices, Monitoring, Endocrinology, FDA Medtronic, Guardian Connect, Continuous Glucose Monitoring, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 12, 2018 Category: Pharmaceuticals Source Type: news

TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding
Company Becomes First to License TAE Technologies' Accelerator-based Beam Technology for Clinical Investigation FOOTHILL RANCH, Calif., March 12, 2018 -- (Healthcare Sales & Marketing Network) -- TAE Life Sciences, a medical technology company develop... Devices, Oncology, Venture Capital, Personnel TAE Life Sciences, neutron beam, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 12, 2018 Category: Pharmaceuticals Source Type: news

SuperSonic Imagine to Showcase Aixplorer(R) Ultimate at 28th Annual Interdisciplinary Breast Center Conference
Live demonstrations will highlight key advances in non-invasive ultrasound for breast disease diagnosis AIX-EN-PROVENCE, France, March 09, 2018 -- (Healthcare Sales & Marketing Network) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company spec... Devices, Product Launch SuperSonic Imagine, Aixplorer, ultrasound, imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 9, 2018 Category: Pharmaceuticals Source Type: news

Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology
INDIANAPOLIS, March 9, 2018 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announced that Maura Dickler, M.D., a prestigious breast cancer researcher, will join Lilly Oncology as Vice President of Late Phase Developme... Biopharmaceuticals, Oncology, Personnel Eli Lilly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 9, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Pivotal Clinical Trial for Technology to Treat Overactive Bladder
NEW YORK, March 9, 2018 -- (Healthcare Sales & Marketing Network) -- Yesterday, the FDA approved the conduct of a pivotal clinical trial using a new technology to treat overactive bladder. The technology, developed and manufactured by Valencia Technologie... Devices, Urology, FDA Valencia Technologies, overactive bladder, eCoin , neuromodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 9, 2018 Category: Pharmaceuticals Source Type: news

CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology
SEATTLE, March 9, 2018 -- (Healthcare Sales & Marketing Network) -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that results from the Phase 3 PERSIST-2 clinical trial of pacritinib (an investigational JAK2 inhibitor) have been publi... Biopharmaceuticals, Oncology CTI BioPharma, pacritinib, JAK2 inhibitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 9, 2018 Category: Pharmaceuticals Source Type: news

Sanofi Completes Acquisition of Bioverativ Inc.
Bioverativ Inc. is a fully owned subsidiary of Sanofi Paris (France) - March 8, 2018 -- (Healthcare Sales & Marketing Network) -- Sanofi announced today the successful completion of its acquisition of Bioverativ Inc. ("Bioverativ") for $105 pe... Biopharmaceuticals, Mergers & Acquisitions Sanofi, Bioverativ, hemophilia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 8, 2018 Category: Pharmaceuticals Source Type: news

Roche launches the new cobas m 511 analyzer, signaling a new era in hematology testing
Clinicians to benefit from integrated workflow and faster access to abnormal results INDIANAPOLIS, March 8, 2018 -- (Healthcare Sales & Marketing Network) -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its new hematology testing solution, t... Diagnostics, FDA, Product Launch Roche Group, cobas m 511, hematology analyzer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 8, 2018 Category: Pharmaceuticals Source Type: news

Paragon 28(R) Announces Launch of Transformational Technology to Correct Hammertoe Deformities-Paragon 28(R) HammerTube(TM) System
ENGLEWOOD, Colo., March 8, 2018 -- (Healthcare Sales & Marketing Network) -- Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28&r... Devices, Orthopaedic, Product Launch Paragon 28, Hammertoe, HammerTube (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 8, 2018 Category: Pharmaceuticals Source Type: news

Infinity Pharmaceuticals Announces Additions to Board of Directors and Clinical Leadership Team and Establishes Scientific Advisory Board
David Beier Appointed to Board of Directors Leadership Team Expanded with Addition of VP Clinical Development Dr. Marie-Louise Fjällskog and Promotion of Dr. Suresh Mahabhashyam Scientific Advisory Board Established with Thought Leaders in Immun... Biopharmaceuticals, Oncology, Personnel Infinity Pharmaceuticals, IPI-549 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 8, 2018 Category: Pharmaceuticals Source Type: news

Spinal Singularity Treats First Patient in Clinical Feasibility Study in US
SAN CLEMENTE, Calif., March 8, 2018 -- (Healthcare Sales & Marketing Network) -- Spinal Singularity announced that the first patient has been treated with the Connected Catheter, an innovative, smart catheter system designed for adult males with Chronic U... Devices, Urology Spinal Singularity, Connected Catheter, NLUTD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 8, 2018 Category: Pharmaceuticals Source Type: news

Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases
Lead investor Venrock joined by Celgene, Lightstone and DROIA Markus Renschler, M.D., joins as CEO, from Celgene Financing proceeds will be used to advance RAD51 inhibitor toward the clinic and expand small-molecule synthetic lethality platform for o... Biopharmaceuticals, Oncology, Venture Capital Cyteir Therapeutics, RAD51 transport (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 8, 2018 Category: Pharmaceuticals Source Type: news

EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research
Programme aims to advance knowledge in type 1 diabetes with support for research projects over three years INDIANAPOLIS, March 8, 2018 -- (Healthcare Sales & Marketing Network) -- The European Foundation for the Study of Diabetes (EFSD), JDRF and Eli L... Biopharmaceuticals, Endocrinology Eli Lilly, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 8, 2018 Category: Pharmaceuticals Source Type: news

BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
Conference Call and Webcast @ 8:30 a.m. Eastern Time Today NEW YORK and PETACH TIKVAH, Israel, March 8, 2018 -- (Healthcare Sales & Marketing Network) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technolog... Regenerative Medicine, Neurology BrainStorm Cell Therapeutics, NurOwn , stem cell, amyotrophic lateral sclerosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 8, 2018 Category: Pharmaceuticals Source Type: news

New Blood Test to Accurately Detect Fibromyalgia Now Available from Data Science Company IQuity
Groundbreaking test offers yes or no answer and speeds time to diagnosis NASHVILLE, Tenn., March 7, 2018 -- (Healthcare Sales & Marketing Network) -- Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia™, a pione... Diagnostics, Product Launch IQuity, IsolateFibromyalgia, fibromyalgia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 7, 2018 Category: Pharmaceuticals Source Type: news

Corin Group Launches Unity Knee(TM) with EquiBalance(TM) at AAOS 2018 Annual Meeting
New System Facilitates Ligament Balancing, Soft Tissue Preservation to Improve Joint Stability and Function, Minimize Pain After Total Knee Replacement NEW ORLEANS, March 7, 2018 -- (Healthcare Sales & Marketing Network) -- Corin Group, a global ortho... Devices, Orthopaedic, Product Launch Corin Group, Unity Knee, EquiBalance, total knee (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 7, 2018 Category: Pharmaceuticals Source Type: news